Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,370 | 3 | 77.0% |
| Travel and Lodging | $996.67 | 4 | 14.3% |
| Food and Beverage | $606.95 | 11 | 8.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $6,959 | 17 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $14.18 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,324 | 6 | Gilead Sciences, Inc. ($1,310) |
| 2022 | $5,650 | 12 | Gilead Sciences, Inc. ($5,650) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Consulting Fee | Cash or cash equivalent | $1,030.00 | General |
| Category: COVID-19 | ||||||
| 10/13/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $114.70 | General |
| 10/12/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $103.92 | General |
| 08/08/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.59 | General |
| 08/03/2023 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/27/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.55 | General |
| 12/01/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $37.90 | General |
| Category: COVID-19 | ||||||
| 12/01/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $25.75 | General |
| Category: COVID-19 | ||||||
| 11/30/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Consulting Fee | Cash or cash equivalent | $3,290.00 | General |
| Category: COVID-19 | ||||||
| 11/18/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $42.86 | General |
| Category: COVID-19 | ||||||
| 11/18/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $42.86 | General |
| Category: COVID-19 | ||||||
| 11/18/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $42.85 | General |
| Category: COVID-19 | ||||||
| 11/18/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $39.40 | General |
| Category: COVID-19 | ||||||
| 11/17/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $394.09 | General |
| Category: COVID-19 | ||||||
| 11/17/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $349.97 | General |
| Category: COVID-19 | ||||||
| 11/17/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $226.86 | General |
| Category: COVID-19 | ||||||
| 11/17/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $107.14 | General |
| Category: COVID-19 | ||||||
| 10/13/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| Category: COVID-19 | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 149 | 283 | $101,458 | $31,535 |
| 2022 | 4 | 156 | 287 | $101,220 | $31,427 |
| 2021 | 4 | 172 | 439 | $159,313 | $50,692 |
| 2020 | 3 | 126 | 315 | $92,014 | $28,925 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 65 | 146 | $42,870 | $14,372 | 33.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 20 | 51 | $30,447 | $9,052 | 29.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 28 | $15,716 | $4,051 | 25.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 47 | $9,071 | $3,157 | 34.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 11 | 11 | $3,354 | $902.62 | 26.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 78 | 188 | $52,452 | $16,055 | 30.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 49 | 49 | $26,558 | $8,126 | 30.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 17 | 30 | $17,910 | $5,740 | 32.1% |
| 99356 | Extended inpatient or observation hospital service, first hour | Facility | 2022 | 12 | 20 | $4,300 | $1,505 | 35.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 100 | 278 | $77,562 | $24,672 | 31.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 21 | 96 | $57,312 | $18,287 | 31.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 32 | 32 | $17,344 | $5,212 | 30.0% |
| 99356 | Prolonged inpatient or observation hospital service, first hour | Facility | 2021 | 19 | 33 | $7,095 | $2,521 | 35.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 80 | 262 | $73,098 | $23,095 | 31.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 23 | 23 | $12,466 | $3,385 | 27.2% |
| 99356 | Prolonged inpatient or observation hospital service first hour | Facility | 2020 | 23 | 30 | $6,450 | $2,445 | 37.9% |
About William Garneau
William Garneau is a Addiction Medicine healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2016. The National Provider Identifier (NPI) number assigned to this provider is 1629431796.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, William Garneau has received a total of $6,974 in payments from pharmaceutical and medical device companies, with $1,324 received in 2023. These payments were reported across 18 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($5,370).
As a Medicare-enrolled provider, Garneau has provided services to 603 Medicare beneficiaries, totaling 1,324 services with total Medicare billing of $142,579. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Addiction Medicine
- Other Specialties Internal Medicine
- Location Baltimore, MD
- Active Since 04/05/2016
- Last Updated 01/30/2026
- Taxonomy Code 207RA0401X
- Entity Type Individual
- NPI Number 1629431796
Products in Payments
- Veklury (Drug) $6,680
- XARELTO (Drug) $14.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Addiction Medicine Doctors in Baltimore
Dr. Marc Fishman, M.d, M.D
Addiction Medicine — Payments: $119,650
Nishant Shah
Addiction Medicine — Payments: $15,382
Alan Geringer, M.d, M.D
Addiction Medicine — Payments: $3,357
Jasleen Salwan, M.d, M.D
Addiction Medicine — Payments: $1,330
Aisosioya Williams, Md, MD
Addiction Medicine — Payments: $1,031
Marian Currens
Addiction Medicine — Payments: $746.16